Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials

OBJECTIVE: Data from two double-blind, randomized, Phase III studies were analysed to investigate the ability of Routine Assessment of Patient Index Data 3, DAS28 (CRP), modified (M)-DAS28 (CRP) and Simplified or Clinical Disease Activity Indices to predict structural damage progression in RA. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Keystone, Edward C, Ahmad, Harris A, Yazici, Yusuf, Bergman, Martin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382603/
https://www.ncbi.nlm.nih.gov/pubmed/31819995
http://dx.doi.org/10.1093/rheumatology/kez455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382603/
https://www.ncbi.nlm.nih.gov/pubmed/31819995
http://dx.doi.org/10.1093/rheumatology/kez455

Ejemplares similares